Experts: Revoke Avastin approval as breast cancer treatment
Wednesday 21 July 2010
A panel of experts on Tuesday recommended that the US Food and Drug Administration (FDA) withdraw approval of Roche's best-selling cancer drug Avastin for the treatment of breast cancer.
Experts on the advisory panel voted 12 to one to recommend that the FDA remove the indication from Avastin's label that the drug be used with chemotherapy to treat advanced breast cancer.
The recommendation came after trials showed that taking Avastin did not benefit patients with metastatic breast cancer and "that there were, indeed, more side effects when patients took Avastin," FDA spokeswoman Karen Riley told AFP.
Avastin had been approved for treatment of advanced breast cancer under the FDA's accelerated approval program, which allows provisional approval of medicines for cancer or other life-threatening diseases.
The final decision on whether to remove the breast cancer indication from the Avastin label will be taken by the FDA and will only affect the use of Avastin to treat breast cancer patients in the United States.
"The recommendation does not impact the use of Avastin for advanced breast cancer in other countries," Genentech, the Roche-owned pharmaceutical company that makes Avastin, said in a statement.
Riley was unable to say when the FDA will make its decision on whether or not to remove the breast cancer indication from Avastin's US label. Genentech said the decision was expected by mid-September.
The panel's recommendation does not affect the use of Avastin to treat other cancers, including colon and lung cancers.
Life & Style blogs
Best three-ingredient recipes: From Nutella brownies to mac and cheese and pulled pork
Topshop pulls 'ridiculously skinny' mannequins after being shamed by customer on Facebook
Windows 10: Is it worth downloading new PC operating system?
What do the emojis on Snapchat mean?
The lesser known erogenous zones - and how to find them
- 1 Norwich paedophile ring: Woman at centre of gang who made children 'sexual play things' guilty of 23 offences
- 2 Kate Winslet thanked 'particularly horrible' girl who bullied her at school after Titanic success
- 3 Black and ethnic minority people twice as likely to be hit by Tory cuts than white people, report finds
- 4 Walter Palmer: Cecil the lion killer revealed to be American dentist
- 5 The lesser known erogenous zones - and how to find them
£28000 - £32000 per annum: Recruitment Genius: This company is an independent ...
£14625 - £20625 per annum: Recruitment Genius: This role is for an enthusiasti...
£45 - £55k DOE: Guru Careers: A Financial Controller is required to join a suc...
Negotiable: Recruitment Genius: This is an exciting opportunity to join the ho...